Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker LMAT
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Bridget A Ross Director | LMAT LeMaitre Vascular, Inc. | 4,322 | $449.2K | — | Jul 29, 2026 | — | Form 144 ↗ |
| May 8, 2026 | Trent G Kamke Officer | LMAT LeMaitre Vascular, Inc. | 2,928 | $313.3K | — | May 8, 2026 | Form 4 ↗ 3 days later · 2,928 shares | Form 144 ↗ |
| May 7, 2026 | Bridget A Ross Director | LMAT LeMaitre Vascular, Inc. | 5,044 | $560.4K | — | May 7, 2026 | Form 4 ↗ 4 days later · 5,044 shares | Form 144 ↗ |
| May 7, 2026 | Lawrence J. Jasinski Director | LMAT LeMaitre Vascular, Inc. | 3,943 | $433.7K | — | May 7, 2026 | Form 4 ↗ 4 days later · 3,943 shares | Form 144 ↗ |
| Mar 11, 2026 | Trent G Kamke Officer | LMAT LeMaitre Vascular, Inc. | 2,625 | $284.8K | — | Mar 11, 2026 | Form 4 ↗ 2 days later · 2,625 shares | Form 144 ↗ |
| Mar 11, 2026 | David B. Roberts Officer | LMAT LeMaitre Vascular, Inc. | 3,312 | $357.9K | — | Mar 11, 2026 | Form 4 ↗ 2 days later · 3,312 shares | Form 144 ↗ |
| Mar 2, 2026 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 200,000 | $21.4M | — | Mar 2, 2026 | Form 4 ↗ same day · 55,930 shares | Form 144 ↗ |
| Feb 27, 2026 | Trent G Kamke Officer | LMAT LeMaitre Vascular, Inc. | 1,044 | $115.1K | — | Feb 27, 2026 | Form 4 ↗ 3 days later · 1,044 shares | Form 144 ↗ |
| Feb 27, 2026 | David B. Roberts Affiliate | LMAT LeMaitre Vascular, Inc. | 8,464 | $962.3K | — | Feb 27, 2026 | Form 4 ↗ 3 days later · 8,464 shares | Form 144 ↗ |
| Feb 26, 2026 | George W. LeMaitre Officer, Director | LMAT LeMaitre Vascular, Inc. | 50,000 | $5.7M | 10b5-1 | Feb 26, 2026 | Form 4 ↗ 4 days later · 205,930 shares | Form 144 ↗ |
| Feb 26, 2026 | George W. LeMaitre Officer, Director | LMAT LeMaitre Vascular, Inc. | 100,000 | $10.4M | 10b5-1 | Feb 26, 2026 | Form 4 ↗ 4 days later · 205,930 shares | Form 144 ↗ |
| Aug 12, 2025 | Lawrence J. Jasinski Director | LMAT LeMaitre Vascular, Inc. | 976 | $90.6K | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 976 shares | Form 144 ↗ |
| Aug 11, 2025 | John Adam Roush Director | LMAT LeMaitre Vascular, Inc. | 6,561 | $607.2K | — | Aug 11, 2025 | Form 4 ↗ 2 days later · 7,500 shares | Form 144 ↗ |
| Aug 11, 2025 | David Roberts Officer, Director | LMAT LeMaitre Vascular, Inc. | 10,815 | $999.2K | — | Aug 11, 2025 | Form 4 ↗ 2 days later · 10,815 shares | Form 144 ↗ |
| Aug 8, 2025 | John Adam Roush Director | LMAT LeMaitre Vascular, Inc. | 939 | $87.8K | — | Aug 8, 2025 | Form 4 ↗ 5 days later · 7,500 shares | Form 144 ↗ |
| Aug 8, 2025 | Bridget A Ross Director | LMAT LeMaitre Vascular, Inc. | 2,500 | $235.0K | — | Aug 8, 2025 | Form 4 ↗ 5 days later · 2,500 shares | Form 144 ↗ |
| Aug 6, 2025 | George W. LeMaitre Officer, Director | LMAT LeMaitre Vascular, Inc. | 100,000 | $9.4M | 10b5-1 | Aug 6, 2025 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| May 12, 2025 | Bridget A. Ross Director | LMAT LeMaitre Vascular, Inc. | 3,750 | $312.0K | — | May 12, 2025 | Form 4 ↗ 2 days later · 3,750 shares | Form 144 ↗ |
| Mar 13, 2025 | Trent G Kamke Officer | LMAT LeMaitre Vascular, Inc. | 4,520 | $360.1K | — | Mar 13, 2025 | Form 4 ↗ 1 day later · 6,529 shares | Form 144 ↗ |
| Mar 12, 2025 | Trent G. Kamke Officer | LMAT LeMaitre Vascular, Inc. | 2,009 | $165.0K | — | Mar 12, 2025 | Form 4 ↗ 2 days later · 6,529 shares | Form 144 ↗ |
| Mar 5, 2025 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 200,000 | $17.9M | — | Mar 5, 2025 | Form 4 ↗ 76 days later · 100,000 shares | Form 144 ↗ |
| Mar 4, 2025 | Lawrence J. Jasinski Director | LMAT LeMaitre Vascular, Inc. | 3,142 | $289.1K | — | Mar 4, 2025 | Form 4 ↗ 2 days later · 3,142 shares | Form 144 ↗ |
| Nov 15, 2024 | Bridget A. Ross Director | LMAT LeMaitre Vascular, Inc. | 3,750 | $380.5K | — | Nov 15, 2024 | Form 4 ↗ 4 days later · 3,750 shares | Form 144 ↗ |
| Nov 13, 2024 | Martha Shadan Director | LMAT LeMaitre Vascular, Inc. | 1,466 | $151.5K | — | Nov 13, 2024 | Form 4 ↗ 2 days later · 1,466 shares | Form 144 ↗ |
| Aug 13, 2024 | David B. Roberts Officer | LMAT LeMaitre Vascular, Inc. | 3,063 | $251.4K | — | Aug 13, 2024 | — | Form 144 ↗ |
| Jul 12, 2024 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 97,378 | $8.4M | 10b5-1 | Jul 12, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Bridget A. Ross Director | LMAT LeMaitre Vascular, Inc. | 5,500 | $428.9K | — | May 16, 2024 | — | Form 144 ↗ |
| May 6, 2024 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 100,000 | $7.7M | 10b5-1 | May 6, 2024 | — | Form 144 ↗ |
| May 6, 2024 | David B. Roberts Director | LMAT LeMaitre Vascular, Inc. | 5,025 | $380.3K | — | May 6, 2024 | — | Form 144 ↗ |
| May 6, 2024 | George W. LeMaitre Officer, Director | LMAT LeMaitre Vascular, Inc. | 100,000 | $7.4M | — | May 6, 2024 | — | Form 144 ↗ |
| Mar 8, 2024 | Trent G Kamke Officer | LMAT LeMaitre Vascular, Inc. | 4,542 | $309.7K | — | Mar 8, 2024 | — | Form 144 ↗ |
| Mar 5, 2024 | Lawrence J. Jasinski Director | LMAT LeMaitre Vascular, Inc. | 5,110 | $344.9K | — | Mar 5, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | John A. Roush Director | LMAT LeMaitre Vascular, Inc. | 7,500 | $525.0K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Joseph P. Pellegrino Jr. Officer | LMAT LeMaitre Vascular, Inc. | 36,967 | $2.4M | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 100,000 | $7.0M | — | Feb 29, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | LeMaitre George W (LMAT) Officer | LMAT LeMaitre Vascular, Inc. | 27,859 | $1.7M | — | Feb 29, 2024 | — | Form 144 ↗ |
| Dec 7, 2023 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 100,000 | $5.4M | — | Dec 7, 2023 | — | Form 144 ↗ |
| Jun 2, 2023 | Bridget A. Ross Director | LMAT LeMaitre Vascular, Inc. | 5,000 | $321.2K | — | Jun 2, 2023 | — | Form 144 ↗ |
| May 16, 2023 | George W. LeMaitre Director | LMAT LeMaitre Vascular, Inc. | 46,472 | $3.0M | — | May 16, 2023 | — | Form 144 ↗ |
| May 9, 2023 | Lawrence J. Jasinski Director | LMAT LeMaitre Vascular, Inc. | 3,648 | $244.4K | — | May 9, 2023 | — | Form 144 ↗ |
| May 9, 2023 | John A. Roush Director | LMAT LeMaitre Vascular, Inc. | 7,500 | $487.5K | — | May 9, 2023 | — | Form 144 ↗ |
| May 4, 2023 | David B. Roberts Officer | LMAT LeMaitre Vascular, Inc. | 26,290 | $1.6M | — | May 4, 2023 | — | Form 144 ↗ |
| May 4, 2023 | David B. Roberts Director | LMAT LeMaitre Vascular, Inc. | 8,699 | $565.1K | — | May 4, 2023 | — | Form 144 ↗ |
| May 3, 2023 | George W. LeMaitre Officer | LMAT LeMaitre Vascular, Inc. | 100,000 | $6.4M | 10b5-1 | May 3, 2023 | — | Form 144 ↗ |
44 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances